Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMJGleeson Regulatory News (GLE)

Share Price Information for MJGleeson (GLE)

Share Price is delayed by 15 minutes
Get Live Data
248.50    3.50 (1.43%)
Bid:
249.00
Ask:
251.00
Spread: 2.00 (0.803%)
Market Cap: £144.97m
GLE Live PriceLast checked at - London Stock Exchange

Intraday MJGleeson Share Chart

Result of AGM

7 Dec 2018 10:41

RNS Number : 8268J
MJ Gleeson PLC
07 December 2018
 

MJ GLEESON plc

Incorporated in England and Wales

Registration number: 09268016

LEI: 21380064K7N2W7FD6434

ISIN: GB00BRKD9Z53

 

 

MJ Gleeson plc

("the Company")

 

 

MJ Gleeson plc - AGM Results

 

The Company announces that all the resolutions put to the Annual General Meeting held at 11.30 a.m. on 6th December 2018 were passed on a show of hands.

 

The following table gives details of the proxy votes lodged with the Company's registrars as at 4 December 2018.

 

Resolution

Total Votes For *(%)

Total Votes Against(%)

Total VotesWithheld

1. To receive and adopt the Accounts for the year ended 30 June 2018 and the Directors' and Auditors' Reports thereon.

35,639,510 (93.89%)

2,318,261 (6.1%)

1,147

2. To approve final dividend of 23p per ordinary share.

37,958,919 (100.00%)

0

(0.0%)

0

3. To re-appoint Stefan Allanson as a Director.

37,928,157 (99.94%)

24,013

 (0.1%)

6,748

4. To re-elect Dermot Gleeson as a Director.

35,565,805 (93.70%)

2,392,443 (6.3%)

670

5. To re-elect Jolyon Harrison as a Director.

37,905,696 (99.86%)

52,093

(0.1%)

1,130

6. To re-elect James Ross Ancell as a Director.

32,329,619 (85.17%)

5,628,170 (14.8%)

1,130

7. To re-elect Christopher Mills as a Director.

31,495,523 (85.20%)

5,471,817 (14.8%)

991,579

8. To re-elect Colin Dearlove as a Director.

35,711,621 (94.08%)

2,246,167 (5.9%)

1,130

9. To re-appoint PricewaterhouseCoopers LLP as Auditors.

37,940,380 (100.00%)

1,550

(0.0%)

16,988

10. To authorise the Directors to determine Auditors' remuneration

37,958,169 (100.00%)

750

(0.0%)

0

11. To approve the Directors' Remuneration Report.

28,474,455 (81.04%)

6,660,072 (19.0%)

2,824,392

12. To authorise the Directors to allot shares in the Company pursuant to Section 551 of the Companies Act 2006.

37,898,027 (99.97%)

12,711

(0.0%)

48,181

13. To disapply pre-emption rights in connection with a rights issue.

37,891,601 (99.96%)

14,522

(0.0%)

52,796

14. To disapply pre-emption rights in connection with allotment of equity securities or sale of treasury shares.

37,880,853 (99.93%)

25,269

(0.1%)

52,796

15. To authorise the Company to purchase its own shares under Section 701 of the Companies Act 2006.

37,888,253 (99.95%)

17,869

(0.0%)

52,796

16. To authorise the Company to call General Meetings other than Annual General Meetings on not less than 14 clear days' notice.

37,708,652 (99.48%)

198,096

(0.5%)

52,171

* Includes discretionary votes

 

 

 

Notes:

 

(1) A "vote withheld" is not a vote in law and is not counted in the total number of votes cast for or against a resolution.

 

(2) Resolutions 1-12 were ordinary resolutions and resolutions 13-16 were special resolutions.

 

Copies of the special business resolutions passed at the Annual General Meeting will shortly be available for inspection via the Financial Services Authority's National Storage Mechanism in accordance with 9.6.2(R) of the Listing Rules

 

There were 54,587,753 ordinary shares of 2p each in issue on 6 December 2018.

 

Further information is available from:

 

MJ Gleeson plc

Stefan Allanson

Chief Financial Officer & Company Secretary

 

Tel: 01142 612900

 

7 December 2018

 

 

END

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
RAGFMMGZGNLGRZM
Date   Source Headline
2nd Jun 20267:00 amRNSBoard Committee Changes
7th May 20264:36 pmRNSDirector/PDMR Shareholding
7th May 20262:49 pmRNSDirector/PDMR Shareholding
1st May 20267:00 amRNSTrading Update
23rd Apr 20267:00 amRNSNotice of Trading Updates and FY2026 Results
14th Apr 20269:34 amRNSDirector/PDMR Shareholding
14th Apr 20269:33 amRNSDirector/PDMR Shareholding
6th Mar 20263:19 pmRNSDirector/PDMR Shareholding
2nd Mar 20264:04 pmRNSHolding(s) in Company
11th Feb 20267:00 amRNSResults for the half year ended 31 December 2025
9th Feb 202610:47 amRNSDirector/PDMR Shareholding
9th Feb 20267:00 amRNS-RPresentation of HY Results on Engage Investor
16th Jan 20267:00 amRNSTrading Update and Notice of Results
6th Jan 20264:40 pmRNSDirector/PDMR Shareholding
9th Dec 202511:31 amRNSDirector/PDMR Shareholding
25th Nov 20251:01 pmRNSDirector/PDMR Shareholding
20th Nov 20253:25 pmRNSHolding(s) in Company
14th Nov 20252:46 pmRNSResult of AGM
14th Nov 20257:01 amRNSAppointment of Non-Executive Director
14th Nov 20257:00 amRNSAGM Trading Update
6th Nov 20255:09 pmRNSDirector/PDMR Shareholding
24th Oct 20254:16 pmRNSDirector/PDMR Shareholding
23rd Oct 20255:07 pmRNSDirector/PDMR Shareholding
20th Oct 20254:09 pmRNSDirector/PDMR Shareholding
17th Oct 20257:00 amRNSNotice of AGM
7th Oct 20253:18 pmRNSDirector/PDMR Shareholding
22nd Sep 20255:01 pmRNSREPLACEMENT: Director/PDMR Shareholding
18th Sep 20257:00 amRNS-RPresentation on Engage Investor Platform
17th Sep 20254:23 pmRNSDirector/PDMR Shareholding
16th Sep 20257:00 amRNSAudited results for the year ended 30 June 2025
9th Sep 202510:45 amRNSDirector/PDMR Shareholding
13th Aug 20257:00 amRNSNotice of Full-Year Results and Presentation
7th Aug 20253:05 pmRNSDirector/PDMR Shareholding
10th Jul 20254:17 pmRNSDirector/PDMR Shareholding
9th Jul 20251:05 pmRNSHolding(s) in Company
8th Jul 20254:00 pmRNSDirector/PDMR Shareholding
7th Jul 20253:11 pmRNSHolding(s) in Company
4th Jul 20257:00 amRNSDirectorate Change
4th Jul 20257:00 amRNSTrading Statement
12th Jun 20253:21 pmRNSDirector/PDMR Shareholding
10th Jun 202511:34 amRNSDirector/PDMR Shareholding
6th Jun 20257:00 amRNSHolding(s) in Company
4th Jun 20255:06 pmRNSDirector/PDMR Shareholding
3rd Jun 20257:03 amRNSTrading Update
7th May 20252:33 pmRNSDirector/PDMR Shareholding
24th Apr 20257:00 amRNSDirectorate Change
8th Apr 20255:22 pmRNSDirector/PDMR Shareholding
8th Apr 20255:17 pmRNSDirector/PDMR Shareholding
6th Mar 20254:52 pmRNSDirector/PDMR Shareholding
5th Mar 20252:54 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.